Clinical Trial

Massed Prolonged Exposure for PTSD in Substance Use Treatment

Study acronym: PREVAIL
Recruiting
View on ClinicalTrials.gov →
Summary
The goal of this clinical trial is to learn if receiving Prolonged Exposure Therapy for PTSD in massed format (multiple sessions weekly) is as effective as receiving it with sessions once per week among veterans with PTSD and substance use disorder in intensive outpatient substance use treatment. The main questions it aims to answer are: * Will the massed format help participants complete and benefit from Prolonged Exposure in terms of PTSD symptoms? * Will it help participants reduce substance use? Participants who are in intensive substance use treatment will be asked to complete Prolonged Exposure with either weekly sessions or multiple sessions per week.
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2024-02-28.
Status change: Not Yet Recruiting → Recruiting 2025-04-16
Trial Details
NCT Number NCT06296186
Lead Sponsor Veterans Medical Research Foundation
Collaborators: University of Minnesota, Center for Veterans Research and Education
Conditions Stress Disorders, Post-Traumatic, Substance Use Disorders
Enrollment 200 participants
Start Date 2024-09-01
Primary Completion 2027-07 (estimated)
Study Completion 2027-08 (estimated)
Updated on ClinicalTrials.gov 2025-04-22